Dhiraj H. Malkani
CHIEF STRATEGY OFFICER · Kiniksa Pharmaceuticals International, plc
Individual
- 2026
- Jul 6, 2026
- 1
Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Dhiraj H. Malkani files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Sanj K. Patel - $39.43M in KNSA purchases and sales in the last 12 months
- John F. Paolini - $8.00M in KNSA purchases and sales in the last 12 months
- Mark Ragosa - $3.78M in KNSA purchases and sales in the last 12 months
- Michael R. Megna - $2.64M in KNSA purchases and sales in the last 12 months
- Barry D. Quart - $1.85M in KNSA purchases and sales in the last 12 months
- Eben Tessari - $523K in KNSA purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Dhiraj H. Malkani?
Dhiraj H. Malkani is a corporate insider, tracked as CHIEF STRATEGY OFFICER of Kiniksa Pharmaceuticals International, plc (KNSA). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Dhiraj H. Malkani last file a Form 4?
The only primary Form 4 on record is dated 6 July 2026.